If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/29/25
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 08/07/25
10 stocks favored to gain up to 30% in a sector that has missed this year's rallyMarket Watch • 07/31/25
DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View RaiseZacks Investment Research • 07/31/25
Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/30/25
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession PlanBusiness Wire • 07/30/25
Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) ProgramBusiness Wire • 07/30/25
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 07/29/25
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing PortfolioBusiness Wire • 07/28/25
Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact?Zacks Investment Research • 07/24/25
Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom IntegrationBusiness Wire • 07/23/25
15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love themMarket Watch • 07/21/25
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 YearsThe Motley Fool • 07/20/25
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark AndrewsBusiness Wire • 07/17/25
DexCom (DXCM) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 07/14/25